All Type of News
48% of drugs being produced at less than 100 million won.
48% of the total drugs in Korea were produced at a value of less than 100 million won a year, implying a necessity for massive product transformations.
The KPMA report revealed that the total 16,061 products were p...
Pharmaceutical stocks to power in Korean Exchange this year
Despite a variety of adverse factors, securities firms hold a rosy outlook for domestic pharmaceutical industry in 2007.
Analysts pick the leading pharmaceutical firms Hanmi Pharm, Dong-A Pharm, Chong Kun Dang, Da...
National health insurance covers BaracludeThe Ministry of Health Welfare said on January 1 that the national health insurance has covered BMS Korea's Baraclude (entecavir). Baraclude 0.5 mg, 1mg tablets are priced at 7,...
|
Many wholesalers to achieve sales more than 100 billion won level.
Amid overall general economic recessions most of local drug wholesalers had achieved their sales at a level of 100 billion won during 2006, showing a rising stance.
Yakup Press reported that as of Dec. 29, 2006 Geo...
Drug identification system to be compulsory for non-reimbursable OTCs
The Korea Food and Drug Administration said on January 2 that it would revise the current drug identification system, in which manufacturers of over-the-counter (OTC) drugs will be required to indicate their OTC dosag...
Top executive organization of Janssen Korea reshuffled.President Park Jae-wha of Janssen Korea, an affiliate of Johnson and Johnson was promoted to the chief executive officer of Hong Kang and Taiwan operation as of Jan. 2, 2007 and...
|
Korean drug makers to release 5 new medicines this year
Korean pharmaceutical firms will launch five new drugs on the domestic market this year following 12 new items, such as Zydena, according to the Korea Drug Research Association.
New medicines that are to be commer...
Korean biopharmaceutical firms join hands with foreign partners via technology transfer
Some Korean biopharmaceutical companies have teamed up with foreign partners in the biotechnology sector via technology tie-ups and joint research collaboration, according to the Korea Health Industry Development Indu...
504 drugs must pass through bio equivalency tests.
Pursuant to the working rules of Pharmaceutical Affairs Act, the KFDA announced on Dec. 27 that all generic drugs containing the total 504 active ingredients should attach its bio equivalency data at the time of produ...
SK Chemcals picks new vice chairman
SK Chemicals said on January 1 that it appointed Choi Chang-won, the current vice president of SK Chemicals as a new vice chairman. SK Chemicals also named four people as executive directors Lee Bong-yong, Oh Myung-w...
